Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-ike particles

Journal of General Virology

Volumn 88, Issue 3, 2007, Pages 792-802

  Ryding, J ^a   Dahlberg, L ^b   Wallen Ohman M ^b   Dillner, Joakim ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Active Biotech Research AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OVALBUMIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; GENETIC ENGINEERING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; VERRUCA VULGARIS; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CAPSID PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNIZATION; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; ONCOGENE PROTEINS, VIRAL; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN PAPILLOMAVIRUS TYPE 16; MUS;

EID: 33847625099     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82449-0     Document Type: Article

References (47)

1. Andersson-Ellstrom, A., Dillner, J., Hagmar, B., Schiller, J., Sapp, M., Forssman, L. & Milsom, I. (1996). Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis 23, 234-238.
2. Bosch, F. X. & de Sanjosé, S. (2003). Chapter 1: Human papilloma-virus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 31, 3-13.
3. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796-802.
4. Brown, D. R., Fife, K. H., Wheeler, C. M., Koutsky, L. A., Lupinacci, L. M., Railkar, R., Suhr, G., Barr, E. & Dicello, A. (2004). Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine. Vaccine 22, 2936-2942.
5. Carter, J. J., Wipf, G. C., Benki, S. F., Christenson, N. D. & Galloway, D. A. (2003). Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. J Virol 77, 11625-11632.
6. Carter, J. J., Wipf, G. C., Madeleine, M. M., Schwartz, S. M., Koutsky, L. A. & Galloway, D. A. (2006). Identification of human papilloma-virus type 16 L1 surface loops required for neutralization by human sera. J Virol 80, 4664-4672.
7. Chackerian, B., Lenz, P., Lowy, D. R. & Schiller, J. T. (2002). Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol 169, 6120-6126.
8. Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G. & Harrison, S. C. (2000). Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 5, 557-567.
9. Christensen, N. D., Hopfl, R., DiAngelo, S. L., Cladel, N. M., Patrick S. D., Welsh, P. A., Budgeon, L. R., Reed, C. A. & Kreider, J. W. (1994). Assembled baculovirus-expressed human papillomavirus type 11 LI capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 75, 2271-2276.
10. Christensen, N. D., Cladel, N. M., Reed, C. A., Budgeon, L. R., Embers, M. E., Skulsky, D. M., McClements, W. L, Ludmerer, S. W. & Jansen, K. U. (2001). Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology 291, 324-334.
11. Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N. & Franceschi, S. (2003). Human papillomavirus; types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88, 63-73.
12. Da Silva, D. M., Pastrana, D. V., Schiller, J. T. & Kest W. M. (2001). Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines. Virology 290, 350-360.
13. De Bruijn, M. L., Greenstone, H. L., Vermeulen, H., Melief, C. J., Lowy, D. R., Schiller, J. T. & Kest W. M. (1998). L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 250, 371-376.
14. de Villiers, E. M., Fauquet C., Broker, T. R., Bernard, H. U. & zur Hausen, H. (2004). Classification of papillomaviruses. Virology 324, 17-27.
15. Dillner, L., Heino, P., Moreno-Lopez, J. & Dillner, J. (1991). Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J Virol 65, 6862-6871.
16. Drobni, P., Mistry, N., McMillan, N. & Evander, M. (2003). Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. Virology 310, 163-172.
17. Dupuy, C., Buzoni-Gatel, D., Touze, A., Le Cann, P., Bout, D. & Coursaget P. (1997). Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb Pathog 22, 219-225.
18. Emini, E. A., Hughes, J. V., Perlow, D. S. & Boger, J. (1985). Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55, 836-839.
19. Ferenczy, A. & Franco, E. (2002). Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3, 11-16.
20. Fife, K. H., Wheeler, C. M., Koutsky, L. A., Barr, E., Brown, D. R., Schiff, M. A., Kiviat, N. B., Jansen, K. U. & Barber, H. (2004). Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. Vaccine 22, 2943-2952.
21. Giroglou, T., Florin, L., Schafer, F., Streeck R. E. & Sapp, M. (2001). Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75, 1565-1570.
22. Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B. & Naud, P. (2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364, 1757-1765.
23. Hopp, T. P. & Woods, K. R. (1981). Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78, 3824-3828.
24. Jameson, B. A. & Wolf, H. (1988). The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 4, 181-186.
25. Joyce, J. G., Tung, J.-S., Przysiecki, C. T., Cook J. C., Lehman, E. D., Sands, J. A., Jansen, K. U. & Keller, P. M. (1999). The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274, 5810-5822.
26. Kimbauer, R., Booy, F., Chang, N., Lowy, D. R. & Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 89, 12180-12184.
27. Koutsky, L. A., Ault K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M. & Jansen, K. U. (2002). A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347, 1645-1651.
28. Le Cann, P., Coursaget, P., Iochmann, S. & Touze, A. (1994). Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbial Lett 117, 269-274.
29. Liu, W. J., Liu, X. S., Zhao, K. N., Leggatt, G. R. & Frazer, I. H. (2000). Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes. Virology 273, 374-382.
30. Longworth, M. S. & Laimins, L. A. (2004). Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68, 362-372.
31. Modis, Y., Trus, B. L. & Harrison, S. C. (2002). Atomic model of the papillomavirus capsid. EMBO J 21, 4754-4762.
32. Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M. & Huh, K. (2004). Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78, 11451-11460.
33. Nieland, J. D., Da Silva, D. M., Velders, M. P., de Visser, K. E., Schiller, J. T., Muller, M. & Kest W. M. (1999). Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune response. J Cell Biochem 73, 145-152.
34. Revaz, V., Benyacoub, J., Kast W. M., Schiller, J. T., De Grandi, P. & Nardelli-Haefliger, D. (2001). Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice. Virology 279, 354-360.
35. Roden, R. B., Armstrong, A., Haderer, P., Christensen, N. D., Hubbert, N. L., Lowy, D. R., Schiller, J. T. & Kimbauer, R. (1997). Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J Virol 71, 6247-6252.
36. Roden, R. B., Ling, M. & Wu, T.-C. (2004). Vaccination to prevent and treat cervical cancer. Hum Pathol 35, 971-982.
37. Rudolf, M. P., Nieland, J. D., DaSilva, D. M., Velders, M. P., Muller, M., Greenstone, H. L., Schiller, J. T. & Kest, W. M. (1999). Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles. Biol Chem 380, 335-340.
38. Ruedl, C., Schwarz, K., Jegerlehner, A., Storni, T., Manolova, V. & Bachmann, M. F. (2005). Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies. J Virol 79, 717-724.
39. Sadeyen, J. R., Tourne, S., Shkreli, M., Sizaret, P. Y. & Coursaget P. (2003). Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. Virology 309, 32-40.
40. Shank-Retzlaff, M., Wang, F., Morley, T., Anderson, C., Hamm, M., Brown, M., Rowland, K., Pancari, G. & Zorman, J. (2005). Correlation between mouse potency and in vitro relative potency for human papillomavirus type 16 virus-like particles and Gardasil vaccine samples. Hum Vaccin 1, 191-197.
41. Slupetzky, K, Shafti-Keramat, S., Lenz, P., Brandt S., Grassauer, A., Sara, M. & Kirnbauer, R. (2001). Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops. J Gen Virol 82, 2799-2804.
42. Touze, A., El Mehdaoui, S., Sizaret, P.-Y., Mougin, C., Muñoz, N. & Coursaget P. (1998). The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol 36, 2046-2051.
43. Villa, L. L., Ault K. A., Giuliano, A. R., Costa, R. L., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A. & Harper, D. M. (2006). Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 24, 5571-5583.
44. Wakabayashi, M. T., Da Silva, D. M., Potkul, R. K. & Kast W. M. (2002). Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Intervirology 45, 300-307.
45. Wang, Z., Christensen, N., Schiller, J. T. & Dillner, J. (1997). A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J Gen Virol 78, 2209-2215.
46. Wang, X., Wang, Z., Christensen, N. D. & Dillner, J. (2003). Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11. Virology 311, 213-22 1.
47. White, W. I., Wilson, S. D., Palmer-Hill, F. J., Woods, R. M., Ghim, S. J., Hewitt, L. A., Goldman, D. M., Burke, S. J. & Jenson, A. B. (1999). Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol 73, 4882-4889.